Sanlam Private Equity acquires majority stake in Southern African medical devices supplier

Sanlam Private Equity, controlled by South African billionaire Patrice Motsepe, has acquired a majority stake in Medhold, a medical devices company established in 1988 that supplies advanced medical technology and services across Southern Africa. The transaction marks a new phase of growth for the supplier, which operates in South Africa, Namibia, Zambia, Zimbabwe and Botswana.

Business Insider Africa reported that Medhold delivers medical devices, technology and software including orthopaedic, diagnostic, theatre, intensive care and robotic-assisted surgical systems. The company provides end-to-end services from product supply and installation to clinical training and after-sales support.

Paul Moeketsi, managing partner at Sanlam Private Equity, said: "As private equity investors, we know that we are uniquely placed to drive real economic change. The philosophy is simple: back resilient businesses that create sustainable value, while also strengthening the country's social and economic fabric. Medhold is one such business."

The deal follows a partnership with Old Mutual Private Equity, which acquired a 50 per cent stake in 2018 and supported Medhold's expansion and operational strengthening. Old Mutual Private Equity has now sold its interest to Sanlam Private Equity, giving Motsepe's firm full majority control.

Brandon Subrayan, investment principal at Sanlam Private Equity, said transactions such as this can help formalise, professionalise and scale mid-market companies, which are the backbone of the South African economy. He added that this creates better-run businesses with strong governance structures, stronger supply chains and more inclusive employment whilst fostering innovation in sectors including healthcare, technology and education.

With Sanlam Private Equity now controlling the company, Medhold plans to expand its product portfolio, reach additional healthcare providers and continue its focus on employee development and socially responsible initiatives. These include training programmes, learnerships and donations to public healthcare facilities.

Access the full transaction details to understand the strategic rationale behind the acquisition.